Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1988 Sep 1;139(5):377–381.

Dietary fish oils containing eicosapentaenoic acid and the prevention of atherosclerosis and thrombosis.

B J Holub 1
PMCID: PMC1268151  PMID: 2842022

Abstract

Recent epidemiologic studies have shown that rates of cardiovascular disease are lower in populations such as the Greenland Eskimos than in those that do not eat seafood, even though the levels of dietary fat intake are often similar. Dietary fish oils are rich in eicosapentaenoic acid (EPA), a polyunsaturated fatty acid of the omega-3 series. EPA has been shown to prolong bleeding time and to decrease platelet aggregation and blood viscosity. EPA inhibits the production of prostaglandins from endogenous arachidonic acid, which is associated with the formation of thromboxane A2 and may also dampen cyclo-oxygenase and lipoxygenase metabolites involved in mediating endothelial cell proliferation. Dietary fish oils are now available in the form of EPA-enriched capsules. Short-term trials in humans have shown that EPA significantly reduces the levels of plasma triglycerides and may increase the levels of high-density lipoproteins; however, no consistent effect on serum cholesterol levels has been shown. The results of evaluations of EPA's use in patients with renal disorders, mild hypertension, inflammatory disorders or hyperlipidemia have been promising. On the basis of the epidemiologic and biologic evidence dietary fish oils warrant further study in extensive clinical trials.

Full text

PDF
377

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed A. A., Holub B. J. Alteration and recovery of bleeding times, platelet aggregation and fatty acid composition of individual phospholipids in platelets of human subjects receiving a supplement of cod-liver oil. Lipids. 1984 Aug;19(8):617–624. doi: 10.1007/BF02534720. [DOI] [PubMed] [Google Scholar]
  2. Braden L. M., Carroll K. K. Dietary polyunsaturated fat in relation to mammary carcinogenesis in rats. Lipids. 1986 Apr;21(4):285–288. doi: 10.1007/BF02536414. [DOI] [PubMed] [Google Scholar]
  3. Bruckner G., Webb P., Greenwell L., Chow C., Richardson D. Fish oil increases peripheral capillary blood cell velocity in humans. Atherosclerosis. 1987 Aug;66(3):237–245. doi: 10.1016/0021-9150(87)90067-0. [DOI] [PubMed] [Google Scholar]
  4. Dyerberg J., Bang H. O. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet. 1979 Sep 1;2(8140):433–435. doi: 10.1016/s0140-6736(79)91490-9. [DOI] [PubMed] [Google Scholar]
  5. Elzinga L., Kelley V. E., Houghton D. C., Bennett W. M. Modification of experimental nephrotoxicity with fish oil as the vehicle for cyclosporine. Transplantation. 1987 Feb;43(2):271–274. doi: 10.1097/00007890-198702000-00021. [DOI] [PubMed] [Google Scholar]
  6. Fischer S., Weber P. C. Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5 omega 3). Biochem Biophys Res Commun. 1983 Nov 15;116(3):1091–1099. doi: 10.1016/s0006-291x(83)80254-x. [DOI] [PubMed] [Google Scholar]
  7. Fuster V., Chesebro J. H. Antithrombotic therapy: role of platelet-inhibitor drugs. I. Current concepts of thrombogenesis: role of platelets. (first of three parts). Mayo Clin Proc. 1981 Feb;56(2):102–112. [PubMed] [Google Scholar]
  8. Grundy S. M. Monounsaturated fatty acids, plasma cholesterol, and coronary heart disease. Am J Clin Nutr. 1987 May;45(5 Suppl):1168–1175. doi: 10.1093/ajcn/45.5.1168. [DOI] [PubMed] [Google Scholar]
  9. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Herold P. M., Kinsella J. E. Fish oil consumption and decreased risk of cardiovascular disease: a comparison of findings from animal and human feeding trials. Am J Clin Nutr. 1986 Apr;43(4):566–598. doi: 10.1093/ajcn/43.4.566. [DOI] [PubMed] [Google Scholar]
  11. Hewitt D., Jones G. J., Godin G. J., McComb K., Breckenridge W. C., Little J. A., Steiner G., Mishkel M. A., Baillie J. H., Martin R. H. Normative standards of plasma cholesterol and triglyceride concentrations in Canadians of working age. Can Med Assoc J. 1977 Nov 5;117(9):1020–1024. [PMC free article] [PubMed] [Google Scholar]
  12. Holub B. J., Bakker D. J., Skeaff C. M. Alterations in molecular species of cholesterol esters formed via plasma lecithin-cholesterol acyltransferase in human subjects consuming fish oil. Atherosclerosis. 1987 Jul;66(1-2):11–18. doi: 10.1016/0021-9150(87)90174-2. [DOI] [PubMed] [Google Scholar]
  13. Holub B. J., Celi B., Skeaff C. M. The alkenylacyl class of ethanolamine phospholipid represents a major form of eicosapentaenoic acid (EPA)-containing phospholipid in the platelets of human subjects consuming a fish oil concentrate. Thromb Res. 1988 Apr 1;50(1):135–143. doi: 10.1016/0049-3848(88)90181-8. [DOI] [PubMed] [Google Scholar]
  14. Ito Y., Barcelli U., Yamashita W., Weiss M., Thompson B., Kashyap M., Deddens J., Pollak V. E. Dietary fat in experimental nephrotic syndrome: beneficial effects of fish oil on serum lipids and, indirectly, on the kidney. Life Sci. 1987 Jun 15;40(24):2317–2324. doi: 10.1016/0024-3205(87)90504-2. [DOI] [PubMed] [Google Scholar]
  15. Jørgensen K. A., Høj Nielsen A., Dyerberg J. Hemostatic factors and renin in Greenland Eskimos on a high eicosapentaenoic acid intake. Results of the Fifth UmanaK Expedition. Acta Med Scand. 1986;219(5):473–479. doi: 10.1111/j.0954-6820.1986.tb03342.x. [DOI] [PubMed] [Google Scholar]
  16. Kondo T., Ogawa K., Satake T., Kitazawa M., Taki K., Sugiyama S., Ozawa T. Plasma-free eicosapentaenoic acid/arachidonic acid ratio: a possible new coronary risk factor. Clin Cardiol. 1986 Sep;9(9):413–416. doi: 10.1002/clc.4960090905. [DOI] [PubMed] [Google Scholar]
  17. Kremer J. M., Jubiz W., Michalek A., Rynes R. I., Bartholomew L. E., Bigaouette J., Timchalk M., Beeler D., Lininger L. Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study. Ann Intern Med. 1987 Apr;106(4):497–503. doi: 10.7326/0003-4819-106-4-497. [DOI] [PubMed] [Google Scholar]
  18. Kromann N., Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand. 1980;208(5):401–406. [PubMed] [Google Scholar]
  19. Kromhout D., Bosschieter E. B., de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985 May 9;312(19):1205–1209. doi: 10.1056/NEJM198505093121901. [DOI] [PubMed] [Google Scholar]
  20. Kyrle P. A., Eichler H. G., Jäger U., Lechner K. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo. Circulation. 1987 May;75(5):1025–1029. doi: 10.1161/01.cir.75.5.1025. [DOI] [PubMed] [Google Scholar]
  21. Mahadevappa V. G., Holub B. J. Quantitative loss of individual eicosapentaenoyl-relative to arachidonoyl-containing phospholipids in thrombin-stimulated human platelets. J Lipid Res. 1987 Nov;28(11):1275–1280. [PubMed] [Google Scholar]
  22. Norell S. E., Ahlbom A., Feychting M., Pedersen N. L. Fish consumption and mortality from coronary heart disease. Br Med J (Clin Res Ed) 1986 Aug 16;293(6544):426–426. doi: 10.1136/bmj.293.6544.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Phillipson B. E., Rothrock D. W., Connor W. E., Harris W. S., Illingworth D. R. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med. 1985 May 9;312(19):1210–1216. doi: 10.1056/NEJM198505093121902. [DOI] [PubMed] [Google Scholar]
  24. Piché L. A., Draper H. H., Cole P. D. Malondialdehyde excretion by subjects consuming cod liver oil vs a concentrate of n-3 fatty acids. Lipids. 1988 Apr;23(4):370–371. doi: 10.1007/BF02537352. [DOI] [PubMed] [Google Scholar]
  25. Robinson D. R., Prickett J. D., Makoul G. T., Steinberg A. D., Colvin R. B. Dietary fish oil reduces progression of established renal disease in (NZB x NZW)F1 mice and delays renal disease in BXSB and MRL/1 strains. Arthritis Rheum. 1986 Apr;29(4):539–546. doi: 10.1002/art.1780290412. [DOI] [PubMed] [Google Scholar]
  26. Rogers S., James K. S., Butland B. K., Etherington M. D., O'Brien J. R., Jones J. G. Effects of a fish oil supplement on serum lipids, blood pressure, bleeding time, haemostatic and rheological variables. A double blind randomised controlled trial in healthy volunteers. Atherosclerosis. 1987 Feb;63(2-3):137–143. doi: 10.1016/0021-9150(87)90113-4. [DOI] [PubMed] [Google Scholar]
  27. Rylance P. B., Gordge M. P., Saynor R., Parsons V., Weston M. J. Fish oil modifies lipids and reduces platelet aggregability in haemodialysis patients. Nephron. 1986;43(3):196–202. doi: 10.1159/000183829. [DOI] [PubMed] [Google Scholar]
  28. Saynor R., Verel D., Gillott T. The long-term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina. Atherosclerosis. 1984 Jan;50(1):3–10. doi: 10.1016/0021-9150(84)90003-0. [DOI] [PubMed] [Google Scholar]
  29. Sekimoto H., Goto Y., Goto Y., Naito C., Yasugi T., Okido M., Kuzuya F., Takeda R., Yamamoto A., Fukuzaki H. Changes of serum total cholesterol and triglyceride levels in normal subjects in Japan in the past twenty years. Research committee on familial hyperlipidemia in Japan. Jpn Circ J. 1983 Dec;47(12):1351–1358. doi: 10.1253/jcj.47.1351. [DOI] [PubMed] [Google Scholar]
  30. Setty B. N., Dubowy R. L., Stuart M. J. Endothelial cell proliferation may be mediated via the production of endogenous lipoxygenase metabolites. Biochem Biophys Res Commun. 1987 Apr 14;144(1):345–351. doi: 10.1016/s0006-291x(87)80516-8. [DOI] [PubMed] [Google Scholar]
  31. Simonsen T., Vårtun A., Lyngmo V., Nordøy A. Coronary heart disease, serum lipids, platelets and dietary fish in two communities in northern Norway. Acta Med Scand. 1987;222(3):237–245. doi: 10.1111/j.0954-6820.1987.tb10665.x. [DOI] [PubMed] [Google Scholar]
  32. Singer P., Wirth M., Voigt S., Richter-Heinrich E., Gödicke W., Berger I., Naumann E., Listing J., Hartrodt W., Taube C. Blood pressure- and lipid-lowering effect of mackerel and herring diet in patients with mild essential hypertension. Atherosclerosis. 1985 Aug;56(2):223–235. doi: 10.1016/0021-9150(85)90021-8. [DOI] [PubMed] [Google Scholar]
  33. Weaver B. J., Holub B. J. The relative degradation of [14C]eicosapentaenoyl and [3H]arachidonoyl species of phosphatidylinositol and phosphatidylcholine in thrombin-stimulated human platelets. Biochem Cell Biol. 1986 Dec;64(12):1256–1261. doi: 10.1139/o86-165. [DOI] [PubMed] [Google Scholar]
  34. Weiner B. H., Ockene I. S., Levine P. H., Cuénoud H. F., Fisher M., Johnson B. F., Daoud A. S., Jarmolych J., Hosmer D., Johnson M. H. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. N Engl J Med. 1986 Oct 2;315(14):841–846. doi: 10.1056/NEJM198610023151401. [DOI] [PubMed] [Google Scholar]
  35. Woodcock B. E., Smith E., Lambert W. H., Jones W. M., Galloway J. H., Greaves M., Preston F. E. Beneficial effect of fish oil on blood viscosity in peripheral vascular disease. Br Med J (Clin Res Ed) 1984 Feb 25;288(6417):592–594. doi: 10.1136/bmj.288.6417.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ziboh V. A., Cohen K. A., Ellis C. N., Miller C., Hamilton T. A., Kragballe K., Hydrick C. R., Voorhees J. J. Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects. Arch Dermatol. 1986 Nov;122(11):1277–1282. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES